Pathological misregulation of mechanosensitive pathways during pregnancy and embryonic development may contribute to the occurrence of cardiovascular birth defects, as well as to a variety of other diseases, including preeclampsia. Thus, there is a need for future studies focusing on better understanding the physiological effects of hemodynamic force during embryonic development and Everolimus clinical trial their role in the pathogenesis of disease. “
“Please cite this paper as: Prabhakarpandian, Wang, Rea-Ramsey, Sundaram, Kiani, and Pant (2011). Bifurcations: Focal Points of Particle Adhesion in Microvascular Networks. Microcirculation. 18(5), 380–389. Objective:  Particle

adhesion in vivo is dependent on the microcirculation environment, which features unique anatomical (bifurcations, tortuosity, cross-sectional changes) and physiological (complex hemodynamics) characteristics. The mechanisms behind these complex phenomena are not well understood. In this study, we

used a recently developed in vitro model of microvascular networks, called SMN, for characterizing particle adhesion patterns in the microcirculation. Methods:  SMNs were fabricated using soft-lithography processes followed by particle adhesion studies using avidin and biotin-conjugated microspheres. Particle adhesion patterns were subsequently analyzed using CFD-based modeling. Results:  Experimental GPCR Compound Library solubility dmso and modeling studies highlighted the complex and heterogeneous fluid flow patterns selleck chemicals encountered by particles in microvascular networks resulting in significantly higher propensity of adhesion (>1.5×) near bifurcations compared with the branches of the microvascular networks. Conclusion:  Bifurcations are the focal points of particle adhesion in microvascular networks. Changing flow patterns and morphology near bifurcations are the primary factors controlling the preferential adhesion of functionalized particles in microvascular networks. SMNs

provide an in vitro framework for understanding particle adhesion. “
“Please cite this paper as: Cromer, Jennings, Odaka, Mathis and Alexander (2010). Murine rVEGF164b, an Inhibitory VEGF Reduces VEGF-A-Dependent Endothelial Proliferation and Barrier Dysfunction. Microcirculation17(7), 536–547. Objective:  To investigate the effects of the murine inhibitory vascular endothelial growth factor (VEGF, rVEGF164b), we generated an adenoviral vector encoding rVEGF164b, and examined its effects on endothelial barrier, growth, and structure. Method:  Mouse vascular endothelial cells (MVEC) proliferation was determined by an MTT assay. Barrier of MVEC monolayers was measured by trans-endothelial electrical resistance (TEER). Reorganization of actin and zonula occludens-1 (ZO-1) were determined by fluorescent microscopy.